lutropin alfa
Selected indexed studies
- Lutropin alfa. (Drugs, 2008) [PMID:18627209]
- Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development. (Drug Saf, 2019) [PMID:30341677]
- Therapeutic management in women with a diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials. (Fertil Steril, 2025) [PMID:39332623]
_Worker-drafted node — pending editorial review._
Connections
lutropin alfa is a side effect of
Sources
- Lutropin alfa. (2008) pubmed
- Dose accuracy of the follitropin alfa pen injector 2.0, the follitropin alfa:lutropin alfa 2:1 combination pen injector 2.0 and the choriogonadotropin alfa pen injector 1.0 used for fertility treatment. (2024) pubmed
- Gonadotropins. (2012) pubmed
- Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development. (2019) pubmed
- Assessment of the biopotency of follitropin alfa and lutropin alfa combined in one injection: a comparative trial in Sprague-Dawley rats. (2008) pubmed
- Lutropin alfa: new preparation. Combined with follitropin for follicular development: no better than menotropin. (2003) pubmed
- Therapeutic management in women with a diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials. (2025) pubmed
- Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment. (2009) pubmed
- Recombinant follitropin alfa/lutropin alfa in fertility treatment. (2010) pubmed
- Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders. (2017) pubmed